United States · FDA National Drug Code directory

PYRUKYND

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71334-210_557b465d-234d-75a2-e063-6394a90a070a
Product NDC
71334-210
Form
TABLET, FILM COATED
Composition / generic term
mitapivat
Labeler
Agios Pharmaceuticals, Inc.
Marketing category
NDA
Marketing start / end (source format)
20220218
Source listing expiry
20271231

Source-listed ingredients

  • MITAPIVAT — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 4 BLISTER PACK in 1 CARTON (71334-210-20) / 14 TABLET, FILM COATED in 1 BLISTER PACK (71334-210-14) · 71334-210-20

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →